Update - Steroidogenic factor 1 (SF-1, NR5A1)

Minerva Endocrinologica

Volumn 35, Issue 2, 2010, Pages 72-85

  Kohler B ^a   Achermann, J C ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenal insufficiency; Fertility; Steroidogenic factor 1

Indexed keywords

INHIBIN B; STEROIDOGENIC FACTOR 1; TESTOSTERONE;

ADRENAL INSUFFICIENCY; CRYPTORCHISM; GENE MUTATION; GONADAL DYSGENESIS; HUMAN; HYPOSPADIAS; KARYOTYPE 46,XX; KARYOTYPE 46,XY; NONHUMAN; OVARY INSUFFICIENCY; PHENOTYPE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEXUAL DEVELOPMENT; TESTOSTERONE BLOOD LEVEL;

EID: 77957710387     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Rice DA, Mouw AR, Bogerd AM, Parker KL. A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1991;5:1552-61.
2. Morohashi K, Honda S, Inomata Y, Handa H, Omura T. A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 1992;267:17913-9.
3. Lala DS, Rice DA, Parker KL. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992;6:1249-58.
4. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993;268:7494-502. (Pubitemid 23105648)
5. Taketo M, Parker KL, Howard TA, Tsukiyama T, Wong M, Niwa O et al. Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. Genomics 1995;25:565-7.
6. Oba K, Yanase T, Nomura M, Morohashi K, Takayanagi R, Nawata H. Structural characterization of human Ad4bp (SF-1) gene. Biochem Biophys Res Commun 1996;226:261-7.
7. Wong M, Ramayya MS, Chrousos GP, Driggers PH, Parker KL. Cloning and sequence analysis of the human gene encoding steroidogenic factor 1. J Mol Endocrinol 1996;17:139-47.
8. Wilson TE, Paulsen RE, Padgett KA, Milbrandt J. Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science 1992;256:107-10.
9. Little TH, Zhang Y, Matulis CK, Week J, Zhang Z, Ramachandran A et al. Sequence-specific deoxyribonucleic acid (DNA) recognition by steroidogenic factor 1: a helix at the carboxy terminus of the DNA binding domain is necessary for complex stability. Mol Endocrinol 2006;20:831-43.
10. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, Wong M et al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res 2002;57:19-36.
11. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-95.
12. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL et al. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 1999;3:521-6. (Pubitemid 29292609)
13. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol Endocrinol 2004;18:2451-62.
14. Lewis AE, Rusten M, Hoivik EA, Vikse EL, Hansson ML, Wallberg AE et al. Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. Mol Endocrinol 2008;22:91-104.
15. Ito M, Yu RN, Jameson JL. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol Endocrinol 1998;12:290-301. (Pubitemid 30658244)
16. Park YY, Park KC, Shong M, Lee SJ, Lee YH, Choi HS. EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation. Mol Cells 2007;24:372-7.
17. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 2005;120:343-55. (Pubitemid 40222429)
18. Hanley NA, Ball SG, Clement-Jones M, Hagan DM, Strachan T, Lindsay S et al. Expression of steroidogenic factor 1 and Wilms' tumour 1 during early human gonadal development and sex determination. Mech Dev 1999;87:175-80. (Pubitemid 29428097)
19. Hanley NA, Ikeda Y, Luo X, Parker KL. Steroidogenic factor 1 (SF-1) is essential for ovarian development and function. Mol Cell Endocrinol 2000;163:27-32.
20. Murayama C, Miyazaki H, Miyamoto A, Shimizu T. Involvement of Ad4BP/SF-1, DAX-1, and COUP-TFII transcription factor on steroid production and luteinization in ovarian theca cells. Mol Cell Biochem 2008;314:51-8.
21. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, Nachtigal MW et al. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994;8:2302-12.
22. Luo X, Ikeda Y, Parker KL. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-90. (Pubitemid 24153989)
23. Bland ML, Fowkes RC, Ingraham HA. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol 2004;18:941-52.
24. Zhao H, Li Z, Cooney AJ, Lan ZJ. Orphan nuclear receptor function in the ovary. Front Biosci 2007;12:3398-405.
25. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, Themmen AP et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 2004;18:1610-9.
26. Zhao L, Kim KW, Ikeda Y, Anderson KK, Beck L, Chase S et al. Central nervous system-specific knockout of steroidogenic factor , results in increased anxiety-like behavior. Mol Endocrinol 2008;22:1403-15. (Pubitemid 351787000)
27. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 2008;453:930-4. (Pubitemid 351832560)
28. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, Sudbeck P et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 1998;18:6653-65.
29. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD, Ingraham HA. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-in sex-specific gene expression. Cell 1998;93:445-54.
30. Tremblay JJ, Viger RS. Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. Mo1 Endocrinol 1999;13:1388-401.
31. Halvorson LM, Ito M, Jameson JL, Chin WW. Steroidogenic factor-1 and early growth response protein 1 act through two composite DNA binding sites to regulate luteinizing hormone beta-subunit gene expression. J Biol Chem 1998;273:14712-20. (Pubitemid 28272755)
32. Dorn C, Ou Q, Svaren J, Crawford PA, Sadovsky Y. Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1. J Biol Chem 1999;274:13870-6.
33. Wilhelm D, Englert C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 2002;16:1839-51. (Pubitemid 34803899)
34. Katoh-Fukui Y, Owaki A, Toyama Y, Kusaka M, Shinohara Y, Maekawa M et al. Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 2005;106:1612-20.
35. Zubair M, Ishihara S, Oka S, Okumura K, Morohashi K. Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1. Mol Cell Biol 2006;26:4111-21.
36. Shima Y, Zubair M, Komatsu T, Oka S, Yokoyama C, Tachibana T et al. Pituitary homeobox 2 regulates adrenal4 binding protein/steroidogenic factor-1 gene transcription in the pituitary gonadotrope through interaction with the intronic enhancer. Mol Endocrinol 2008;22:1633-46.
37. Utsunomiya H, Cheng YH, Lin Z, Reierstad S, Yin P, Attar E et al. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol 2008;22:904-14. (Pubitemid 351482826)
38. Xue Q, Un Z, Yin P, Milad MP, Cheng YH, Confino E et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab 2007;92:3261-7.
39. Achermann JC, Ito M, Hindmarsh PC, Jameson JL. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999;22:125-6.
40. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 2002;87:1829-33. (Pubitemid 34615276)
41. Ito M, Achermann JC, Jameson JL. A naturally occurring steroidogenic factor-1 mutation exhibits differential binding and activation of target genes. J Biol Chem 2000;275:31708-14.
42. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000;67:1563-8.
43. Ozisik G, Achermann JC, Meeks JJ, Jameson JL. SF1 in the development of the adrenal gland and gonads. Horm Res 2003;59 Suppl 1:94-8. (Pubitemid 36173415)
44. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, Jameson JL et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab 2006;91:3048-54.
45. Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, Parker KL et al. A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 2004;89:1767-72.
46. Mallet D, Bretones P, Michel-Calemard L, Dijoud F, David M, Morel Y. Gonadal dysgenesis without adrenal insufficiency in a 46, XY patient heterozygous for the nonsense Cl6X mutation: a case of SF1 haploinsufficiency. J Clin Endocrinol Metab 2004;89:4829-32.
47. Hasegawa T, Fukami M, Sato N, Katsumata N, Sasaki G, Fukutani K et al. Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab 2004;89:5930-5. (Pubitemid 39628395)
48. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 2007;92:991-9. (Pubitemid 46465674)
49. Coutant R, Mallet D, Lahlou N, Bouhours-Nouet N, Guichet A, Coupris L et al. Heterozygous mutation of steroidogenic factor-1 in 46,XY subjects may mimic partial androgen insensitivity syndrome. J Clin Endocrinol Metab 2007;92:2868-73.
50. Reuter AL, Goji K, Bingham NC, Matsuo M, Parker KL. A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. Eur J Endocrinol 2007;157:233-8.
51. Kohler B, Lin L, Ferraz-de-Souza B, Wieacker P, Heidemann P, Schroder V et al. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency. Hum Mutat 2008;29:59-64.
52. Lourenco D, Brauner R, Lin L, De Perdigo A, Weryha G, Muresan M et al. Mutations in NR5A, associated with ovarian insufficiency. N Engl J Med 2009;360:1200-10.
53. Kohler B, Lin L, Mazen I, Cetindag C, Biebermann H, Akkurt I et al. The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency. Eur J Endocrinol 2009;161:237-42.
54. van Silfhout A, Boot AM, Dijkhuizen T, Hoek A, Nijman R, Sikkema-Raddatz B, van Ravenswaaij-Arts CM. A unique 970kb microdeletion in 9q33.3, including the NR5A1 gene in a 46,XY female. Eur J Med Genet 2009;52:157-60.
55. Schlaubitz S, Yatsenko SA, Smith LD, Keller KL, Vissers LE, Scott DA, Cai WW, Reardon W, Abdul-Rahman OA, Lammer EJ, Lifchez CA, Magenis E, Veltman JA, Stankiewicz P, Zabel BU, Lee B. Ovotestes and XY sex reversal in a female with an interstitial 9q33.3-q34.1 deletion encompassing NR5A1 and LMXlB causing features of Genitopatellar syndrome. Am J Med Genet A 2007;143A:1071-81. (Pubitemid 46709277)
56. Philibert P, Zenary D, Lin L, Soskin S, Audran F, Leger J, Achermann JC, Sultan C. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 2007;22:3255-61.
57. Wada Y, Okada M, Hasegawa T, Ogata T. Association of severe micropenis with Gly146Ala polymorphism in the gene for steroidogenic factor-1. Endocr J 2005;52:445-8.
58. Wada Y, Okada M, Fukami M, Sasagawa I, Ogata T. Association of cryptorchidism with Gly146Ala polymorphism in the gene for steroidogenic factor-1. Fertil Steril 2006,85:787-90. (Pubitemid 43261589)
59. WuQiang F, Yanase T, Wei L, Oba K, Nomura M, Okabe T, Goto K, Nawata H. Functional characterization of a new human Ad4BP/SF-1 variation, G146A. Biochem Biophys Res Commun 2003;311:987-94.
60. Figueiredo BC, Cavalli LR, Pianovski MA, Lalli E, Sandrini R, Ribeiro RC et al. Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. J Clin Endocrinol Metab 2005;90:615-9.
61. Almeida MQ, Soares IC, Ribeiro TC, Fragoso MC, Marins LV, Wakamatsu A et al. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J Clin Endocrinol Metab 2010;95:1458-62
62. Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S et al. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors. J Clin Endocrinol Metab 2007;92:3253-60. (Pubitemid 47236400)
63. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007;21:2968-87. (Pubitemid 350223508)
64. Doghman M, Cazareth J, Douguet D, Madoux F, Hodder P, Lalli E. Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. J Clin Endocrinol Metab 2009;94:2178-83.